Holen Sie sich die Stockscreener-App
27.19
0.07%
-0.02
Handel nachbörslich:
27.19
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt PHG?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$27.21
Offen:
$27.32
24-Stunden-Volumen:
1.09M
Relative Volume:
0.94
Marktkapitalisierung:
$26.43B
Einnahmen:
$20.45B
Nettoeinkommen (Verlust:
$1.12B
KGV:
23.32
EPS:
1.1658
Netto-Cashflow:
$1.75B
1W Leistung:
+2.18%
1M Leistung:
+3.03%
6M Leistung:
+0.41%
1J Leistung:
+13.39%
1-Tages-Spanne:
$26.86
$27.35
1-Wochen-Bereich:
$26.66
$27.59
52-Wochen-Spanne:
$23.75
$33.44
Koninklijke Philips Nv Adr Stock (PHG) Company Profile
Firmenname
Koninklijke Philips Nv Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare PHG vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips Nv Adr
|
27.19 | 26.34B | 20.45B | 1.12B | 1.75B | 1.1658 |
ABT
Abbott Laboratories
|
90.74 | 163.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
314.84 | 127.55B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.23 | 103.66B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
42.68 | 65.74B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.46 | 52.27B | 6.30B | 1.07B | 1.09B | 1.8406 |
Koninklijke Philips Nv Adr Stock (PHG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-17 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-02-25 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | Hochstufung | UBS | Neutral → Buy |
| 2024-10-29 | Hochstufung | Jefferies | Underperform → Hold |
| 2024-05-13 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-04-30 | Hochstufung | UBS | Sell → Neutral |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-01-17 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-14 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-09-12 | Hochstufung | Societe Generale | Hold → Buy |
| 2022-09-06 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-06-16 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-20 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-14 | Hochstufung | HSBC Securities | Hold → Buy |
| 2022-01-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-08 | Eingeleitet | Jefferies | Buy |
| 2021-07-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-06-21 | Herabstufung | HSBC Securities | Buy → Hold |
| 2021-03-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-07-28 | Eingeleitet | Societe Generale | Buy |
| 2019-07-30 | Eingeleitet | Citigroup | Buy |
| 2018-02-12 | Hochstufung | Berenberg | Hold → Buy |
| 2017-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-10-16 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | Herabstufung | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2016-12-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | Eingeleitet | Citigroup | Buy |
| 2016-05-11 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2016-02-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2015-11-27 | Eingeleitet | ING Group | Hold |
| 2015-09-08 | Eingeleitet | Credit Suisse | Outperform |
| 2015-08-27 | Hochstufung | Nomura | Neutral → Buy |
| 2015-07-28 | Hochstufung | Societe Generale | Hold → Buy |
| 2011-01-25 | Herabstufung | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2009-10-16 | Hochstufung | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | Herabstufung | UBS | Buy → Neutral |
Alle ansehen
Koninklijke Philips Nv Adr Aktie (PHG) Neueste Nachrichten
PHIA Forecast — Price Target — Prediction for 2027 - TradingView
Koninklijke Philips N.V. Sponsored ADR Actuals & Estimates (NYSE:PHG) - TradingView
European ADRs Climb In Thursday U.S. Morning Session: ARGX, PHIA, CRTO In Focus - foreignpolicyjournal.com
940936 Forecast — Price Target — Prediction for 2027 - TradingView
Koninklijke Philips N.V. ADR Unsponsored Brazilian Depository Receipt Repr 1 ADR - TradingView
0A2M Forecast — Price Target — Prediction for 2027 - TradingView
Medical Alert System Market Size to Worth $23.5 Billion by 2035 | Research by SNS Insider - GlobeNewswire Inc.
PHGKoninklijke Philips NV ADR Stock Price and Quote - Finviz
[Latest] Healthcare Command Centers Market Size Will Attain USD 5.0 Billion by 2034 Registering a Promising CAGR of 10.8% - GlobeNewswire Inc.
Philips helps customers rethink flexibility with the IntelliVue Patient Monitor 6000 Series - Finviz
Enterprise value to EBITDA ratio of Koninklijke Philips N.V. ADR – BCBA:PHG.CI - TradingView
Koninklijke Philips N.V. Stock (NL0000009538): valuation back in focus after recent restructuring mo - AD HOC NEWS
Philips Future Health Index 2026: AI is already saving clinicians time and delivering measurable impact in healthcare - Sahm
Sony Group Corp. ADR outperforms market on strong trading day - MarketWatch
Sony Group Corp. ADR falls Friday, still outperforms market - MarketWatch
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland - Finviz
symbol__ Stock Quote Price and Forecast - CNN
Philips announces exchange ratio for 2025 dividend - Philips
Disney and Philips bring together beloved storytelling and innovative technology to support kids undergoing MRI exams - Sahm
Koninklijke Philips N.V. stock (NL0000009538): Cybersecurity probe and legal risks move back into fo - AD HOC NEWS
Koninklijke Philips N.V. stock (NL0000009538): Investors react to legal settlement push and portfoli - Ad-hoc-news.de
Koninklijke Philips: AI Upside And Margin Expansion Create An Attractive Entry Point (PHG) - Seeking Alpha
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026 - Sahm
Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures - Sahm
Nebulizers - GlobeNewswire Inc.
Koninklijke Philips N.V. stock (NL0000009538): new SmartIQ imaging launch keeps focus on health-tech - AD HOC NEWS
Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm - Finviz
QuickLogic Posts Downbeat Q1 Results, Joins Resideo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
Koninklijke Philips N.V. stock (NL0000009538): ex-dividend date set for May 12 - AD HOC NEWS
Koninklijke Philips N.V. Stock (NL0000009538): Analyst Rating Change and Price Move on May 7, 2026 - AD HOC NEWS
Philips shareholders approve all proposals at the AGM 2026 - Finviz
Earnings call transcript: Philips Q1 2026 sees solid revenue but EPS miss - Investing.com
Earnings call transcript: Koninklijke Philips misses Q1 2026 EPS forecast By Investing.com - Investing.com Canada
Earnings call transcript: Koninklijke Philips misses Q1 2026 EPS forecast - Investing.com
Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - GlobeNewswire Inc.
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
Sony Group Corp. ADR falls Thursday, underperforms market - MarketWatch
Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction - Sahm
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning - Finviz
Sony Group Corp. ADR falls Monday, underperforms market - MarketWatch
Koninklijke Philips (ADR) stock (NL0000009538): Why Google Discover changes matter more now - AD HOC NEWS
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications - Sahm
Sony Group Corp. ADR rises Friday, still underperforms market - MarketWatch
Philips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications - Finviz
Sony Group Corp. ADR rises Wednesday, still underperforms market - MarketWatch
Koninklijke Philips (ADR) stock (NL0000009538): Why its focus on diagnostics and AI tools matters mo - AD HOC NEWS
Finanzdaten der Koninklijke Philips Nv Adr-Aktie (PHG)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):